Group I (N = 30) | Group II (N = 30) | Group III (N = 30) | Group IV (N = 30) | p-value | ||
---|---|---|---|---|---|---|
Age (year) mean ± SD | 56.77 ± 7.81 | 56.57 ± 8.92 | 56.50 ± 8.96 | 56.63 ± 9.08 | 0.99 | |
BMI (kg/m2) mean ± SD | 23.0 ± 0.7 | 27.3 ± 1.8 | 24 ± 1.3 | 27.3 ± 1.5 | p1, p2, p3, p4, p6 < 0.05 p5 > 0.05 | |
Sex | ||||||
Female | N (%) | 16(53.3%) | 16(53.3%) | 17 (56.7%) | 16(53.3%) | 0.992 |
Male | N (%) | 14(46.7%) | 14(46.7%) | 14(46.7%) | 13 (43.3%) | |
Smoking | N (%) | 8(26.7%) | 18(60.0%) | 9 (30.0%) | 20 (66.7%) | 0.002 |
Familyhistory of premature CAD | N (%) | 6 (20.0%) | 6(20.0%) | 7 (23.3%) | 6(20.0%) | 0.985 |
Hypertension | N (%) | 7 (23.3%) | 22 (73.3%) | 9 (30%) | 20 (66.7%) | 0.006 |
Dyslipidemia (LDL > 100) | N (%) | 20 (66.6%) | 7 (23.3%) | 21 (70%) | 10 (33.3%) | 0.001 |
Ischemic changes | N (%) | 14(46.7%) | 16(53.3%) | 14(46.7%) | 17(56.7%) | 0.852 |
Hemoglobin | 12.83 ± 0.46 | 12.86 ± 0.49 | 12.82 ± 0.5 | 12.59 ± 0.49 | 0.29 | |
Hematocrit | 39.1 ± 0.7 | 42.2 ± 2.5 | 39.5 ± 1.0 | 42.4 ± 2.0 | p2, p3 > 0.05 p 1, p 4 = 0.05 | |
Platelets | 219.7 ± 14.6 | 256.9 ± 19.5 | 211 ± 22.1 | 213.3 ± 21.1 | p2, p4 > 0.05 p1, p3 < 0.05 | |
Leukocytes | 7.8 ± 1.5 | 8.5 ± 1.4 | 8.1 ± 1.3 | 9.3 ± 1.1 | p2 > 0.05 p1, p3,p4 < 0.05 | |
Neutrophil | 3.6 ± 0.6 | 4.6 ± 1.9 | 4.4 ± 1.3 | 6.5 ± 1.6 | p1, p2, p3, p4 < 0.05 | |
Lymphocyte | 2.0 ± 0.4 | 1.9 ± 1.0 | 2.1 ± 0.6 | 1.7 ± 0.6 | 0.215 | |
PLR | 119 ± 33.2 | 150.2 ± 38.6 | 107.3 ± 33.8 | 140.7 ± 58 | p1, p3, p4 < 0.05 p2 > 0.05 | |
NLR | 2 ± 0.6 | 2.6 ± 1.3 | 2.3 ± 1.1 | 4.3 ± 2.1 | p3, p4 < 0.05 p1, p2 > 0.05 | |
CRP | 4.2 ± 0.9 | 7.8 ± 1.1 | 4.2 ± 1.6 | 7.9 ± 1.1 | p1, p3, p4 < 0.05 p2 > 0.05 | |
EF | 58.4 ± 5.24 | 57.53 ± 4.7 | 57.9 ± 5.09 | 58.4 ± 5.24 | 0.9 | |
HbA1C | 5.8 ± 0.2 | 6.1 ± 0.4 | 9.3 ± 0.7 | 9.6 ± 1 | p2, p3, < 0.05 p1, p4 > 0.05 | |
FBS | 104 ± 6.2 | 110 ± 8.5 | 252.6 ± 42 | 271.3 ± 53.1 | p1 = 0.6 p2, p3, p4 = 0.05 |